.pharma
Is .pharma a real TLD? Who’s applying to run it?
.pharma is not contested. One application for it is on ICANN’s Reveal Day list, as of 7 October 2026. It is Radix.
A real industry word, but trust-wary drug companies stick to established domains; expect modest, largely defensive registrations.
pharmaceutical and life-sciences companies, B2B suppliers, CROs, pharma-tech startups, recruiters and industry media wanting an industry-labeled address; large drug brands mostly as defensive registrants
One of 46 ICANN 2026-round applications Radix announced on its own applications page. Radix states it intends to build and operate each TLD it wins.
The 2012 applications making the most similar bet. Chosen by AI from every string in that round, without being told what happened to any of them.
Same bet in the same regulated vertical: a sector-category noun whose whole value is being a gated, eligibility-verified namespace where a licensed incumbent moves its primary identity for the trust signal, not a volume registration play.
The canonical restricted-industry noun bet — a small, high-value, verified registrant base of regulated corporations buying legitimacy and anti-counterfeit assurance rather than cheap available inventory, which is exactly the economics .pharma has to run on.
Also an industry shorthand rather than a full entity noun, sitting in the same healthcare-adjacent gray zone where the operator must decide between a professional-eligibility gate and an open generic, with the same ambiguity about whether anyone treats the abbreviation as their primary identity.
What a .pharma domain is
.pharma is not a TLD yet. It is a string on our record of the ICANN 2026 new gTLD round, in our Other category. One application for it is on ICANN’s Reveal Day list.
Is the .pharma domain extension real yet?
.pharma is not yet a domain extension you can register: nothing resolves under it, and no registrar sells names in it. It is a string applicants have put forward in the ICANN 2026 new gTLD round, the process that decides whether it becomes one.
When can you buy a .pharma domain?
You can’t yet. A .pharma name can only be registered once the string is delegated (added to the DNS root) and its registry opens. Last round's closest parallel to .pharma was .pharmacy, delegated on 5 September 2014.
Is .pharma a real TLD?
Not yet. .pharma is not in the DNS root, so nothing resolves under it. It’s here because .pharma is on ICANN’s Reveal Day list of applied-for strings. Every entry on this page links to its source.
- Band chosen: 30-49, usable but limited, score 35. The string names a large, real global industry with genuine B2B ecosystems (suppliers, contract research, conferences, recruiting, trade media), so demand above vanity level is plausible, and the applicant is a large portfolio registry that states it builds and operates what it wins, which supports distribution and adoption likelihood. It is not in the 50-69 band because the pharmaceutical sector is unusually conservative online: patient-safety and counterfeit-medicine concerns make trust paramount, and by analogy with restricted health-trust TLDs such as .pharmacy — which, as an analogy, achieved credibility positioning but not volume or primary-identity adoption — serious drug makers are unlikely to move primary identities off established domains, leaving mostly defensive and secondary-site use with a thin aftermarket. It is not in the 10-29 band because, by analogy with open industry-term TLDs like .health and .healthcare, an industry keyword backed by a volume-capable registry sustains real registrations and some genuine end-use among smaller pharma-adjacent firms, not merely event-driven or joke demand. Main market uncertainty: whether the TLD is run open or with sector eligibility verification — an open .pharma risks abuse associations (counterfeit-drug sellers) that could depress trust and serious adoption, while a verified model would raise trust but cap volume; exact registration volumes and prices are unknown.